NewAmsterdam Pharma Company NV (NASDAQ: NAMS) is 47.00% higher on its value in year-to-date trading and has touched a low of $5.63 and a high of $26.35 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The NAMS stock was last observed hovering at around $16.10 in the last trading session, with the day’s gains setting it 0.32%.
Currently trading at $16.42, the stock is -0.65% and -9.16% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.2 million and changing 1.99% at the moment leaves the stock -8.95% off its SMA200. NAMS registered 54.76% gain for a year compared to 6-month loss of -30.25%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -4.84% gain in the last 1 month and extending the period to 3 months gives it a -12.43%, and is 0.98% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.45% over the week and 5.83% over the month.
Distance from 52-week low is 191.52% and -37.69% from its 52-week high.
The EPS is expected to shrink by -10.80% this year.
NewAmsterdam Pharma Company NV (NAMS) Top Institutional Holders
112.0 institutions hold shares in NewAmsterdam Pharma Company NV (NAMS), with institutional investors hold 85.51% of the company’s shares. The shares outstanding are 82.47M, and float is at 43.52M with Short Float at 3.88%. Institutions hold 85.28% of the Float.
NewAmsterdam Pharma Company NV (NAMS) Insider Activity
The most recent transaction is an insider purchase by Davidson Michael H.,the company’sChief Executive Officer. SEC filings show that Davidson Michael H. bought 5,000 shares of the company’s common stock on Aug 20 ’24 at a price of $16.27 per share for a total of $81350.0. Following the purchase, the insider now owns 0.21 million shares.
NewAmsterdam Pharma Company NV disclosed in a document filed with the SEC on Jun 20 ’24 that Davidson Michael H. (Chief Executive Officer) bought a total of 5,000 shares of the company’s common stock. The trade occurred on Jun 20 ’24 and was made at $17.26 per share for $86308.0. Following the transaction, the insider now directly holds 0.2 million shares of the NAMS stock.
Still, SEC filings show that on Mar 26 ’24, Topper James N (Director) acquired 8,429 shares at an average price of $21.50 for $0.18 million. The insider now directly holds 3,008,429 shares of NewAmsterdam Pharma Company NV (NAMS).
